{"name":"Dianthus Therapeutics","slug":"dianthus-therapeutics","ticker":"","exchange":"","domain":"dianthus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"pipeline","source":"The Manila Times","summary":"Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times","headline":"Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQY2ZlQWRHVlRkVlozWndsR0xJNG5yZnRmUUpkeXYtdTk4ZWZFZG5pTE9OOEtveEJ0ZHpycTdsYllrX0RxcDBsT0NZczRwTjk4dTdydFBIVi15LW5GbWRGQXJsVmJTNTAxblpTaHZibjRxQzdrcHY4U1RqeWdoTjdrMldBV2ROYWdRdGROQTFJQU01aEJUblVTVTNyQjRqV2xkc0J6RFhvNHpKVkxYblNXTWlpMDlTZFNwSktFTVdVekRFT1ZIbVlxWk9NYU4tQkR4MVFVYkhaaHpkSUJBcmZfYVJlZEc5VWZJUGdqQ0FZOGoxbzUtcW9POERRTTUzMzRUcl9KM2V6UnVfNXpseWJz?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Terns Pharmaceuticals (TERN) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Terns Pharmaceuticals (TERN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxNM3hHVGpha2ZsMVAxemxTLUNDazl4el9ZZUhDS0QtMllhamNCLTBEb2ZubjROWXJ0bWRPSUVFLXNRMDJ3cWtKU2tsZG1tM3BxRGdrS3FkYjE3bWU2LUxCTzQ3dWxKbU9YUTJHbThNQVUwWWV3TWpuVlVuTE9idDVHZFlvdEFPNkhpeWtGR3BscFA3QzRaWnlqYldfZWM1OWMzVlRMYmFONXNfT3FyWXdPcGRLQ0twRVpPYzNlYUpKd3JSLWxJOFExc3JXNUNNeFZrOW82OFU2bUNGb2M4QWN4aUNFdmZ3elJvMzgwZHBPNU9BSFR4S0YwSGpTMmhqa0NLVURlYWFacXIxUnhVQlhNU2ljbDIwMHNZWmFOWlhsUUV5cy1QSmR0WjVFaG9lTVN4ekh5a0xKc0ZZQTY1TkhqaF9n?oc=5","date":"2026-01-14","type":"pipeline","source":"GlobeNewswire","summary":"Generalized Myasthenia Gravis Market Outlook Shows Strong - GlobeNewswire","headline":"Generalized Myasthenia Gravis Market Outlook Shows Strong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNS24xekhvdXA3ZmVGTjljQTNHRmlyZy1XUnNmeU5qel9pc09vN0FRVW1oR1hhcWRuNmsyMTg0UFFFb1VDX09QTUVYeXBjQ242c3NFd01jeXp3TUhyMUg0ZkFvelRTYWthaWV0RW9KekNBUGJQREpoSG9IamgtbTRYUWV0WHhUNThDb0stV1hDaWg1RUdCYWFYaThFVUxOeHdFNHRpVzZtTVBScnFPVmlJeW51NTE?oc=5","date":"2025-12-04","type":"pipeline","source":"News-Medical","summary":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - News-Medical","headline":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPd1hLVnJDZV9wVVczQjhJRnpIeFEyOE4tb1JWUGdRNWllMFdELThrc0RiVzNmSm1JS014Ui10SS1CYzJQT3lhVUZxem5SOXVQWFpacndScXY2V2tveFRRVjEyX3VrY3RQOTN3UDE4VXhKU21rMnhMV2VCRU82TnV5VnFnekswelgwQ2puX1Fhdks3SDdaTmdSRmtqQ2ttMjZSRllmTmNlbU5iQQ?oc=5","date":"2025-12-04","type":"pipeline","source":"PMLiVE","summary":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - PMLiVE","headline":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVjQyTG9TTHJpX1RoanVvX2s5UDVUTnJ5RThWc19BMEg5OElmVjdFZ0kwVl9VYWw0ZHA4dlJpTFBUejk4RnM2SllzelJsb0RiTWpXYlY1VTAzMU5EVXB4Z3ltbUU0WnBFRHg0VkJQWTI1SGNjT3ZBdDFEejgzaUxkSVZpQ2t1SnBGSW4yS0NuTGR0ell6X3hzS0ZWVVktc25PNnNhSnlxdXRLRmVrT3dkQndrSC1TSUxramxOUkdkVi1mTmEz?oc=5","date":"2025-10-17","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP - Fierce Pharma","headline":"Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53RThNa0FDdzlWc2xKZmV1T2VjMGQzXy1yTXVXSzN0cTB2bzNRRXVpVFFSWE9jVzUtOFJ6MmN3UjBxOWc2WVN4Z3h4Tm1ubzM2VjRN?oc=5","date":"2025-10-16","type":"pipeline","source":"FirstWord Pharma","summary":"Dianthus bets up to $1B on Chinese biotech's autoimmune bifunctional - FirstWord Pharma","headline":"Dianthus bets up to $1B on Chinese biotech's autoimmune bifunctional","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQbGVLMFlCaEZyLXJlQmt2ZUJ3T2p2VmF0RjRnM1M1MXlEbGRKOUZYOUMyUkJiN0UwWnBDZ0RMc0M0b2s0TTdibU5NeXRuajNmcFBRMkFBMWppYXp6eWVTOWlpcnR5MXgtQk5Mb2RGdHhxNm5TVzd3aWZPM0lVNWFPTTU2aTAzSHdwMEgxMVVlNXdYenIwVjMxTlN0Ym9pX2wx?oc=5","date":"2025-10-16","type":"pipeline","source":"Fierce Biotech","summary":"Dianthus offers up to $1B for China biotech's autoimmune 'pipeline in a product' - Fierce Biotech","headline":"Dianthus offers up to $1B for China biotech's autoimmune 'pipeline in a product'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOcnduYUlkVFhNU1h1bVZIeU5JWl9CYWtsT3ZlLWR2UzRld2gxdk5YZmZxZXFuZG9fV2thd1BUYTZjbzhlRVo2d01EekQ2TGxwclJOendZc0VXOEF3ZVctOVhZUl9xVlRLVGg4bUJqNnBSb2s5cjA2WnRIRDVjS3ZpbnF5R3F4T1ZUVi14dGZvMTJoTTN0ZU9YVUFpLUwtWXEtZmZBVU8xOG1tZEV6OW1IOFVxOEwyd2MxS1hSek1nSWhtUVlUMEpfRE4tWElSb2tIckhMOENfUG44ODVUSERyYWwxTUU?oc=5","date":"2025-09-13","type":"deal","source":"The Globe and Mail","summary":"TD Cowen Sticks to Its Buy Rating for Dianthus Therapeutics (DNTH) - The Globe and Mail","headline":"TD Cowen Sticks to Its Buy Rating for Dianthus Therapeutics (DNTH)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxON1dOUFhjSjdIZzNwUzRZY0MxNGE0N3BRMEN5dGcxUmwzd0xvcm1nWjAyd0xKWEtMbUcwRVJ4bnZGU2s1MEZUSXVYR3o1dW5jTkdrdU9FemdWT3NmU0RZS0p2YjAxYTZXSDVQbF9wS2w2YmdNTnlBajZxcVlLMjFHZGJpUTE0T1pZUVQ3d1drMGVNQTBkLVAxMTFwT181ck1ha3c?oc=5","date":"2025-09-08","type":"trial","source":"Fierce Biotech","summary":"Dianthus' gMG prospect blooms, with phase 2 win setting up pivotal plans - Fierce Biotech","headline":"Dianthus' gMG prospect blooms, with phase 2 win setting up pivotal plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TcTB0SzNYd091QW10LTVyRWQ3cy1BTmpqLVR0RzlCX3FPc01kdHVFRlItM25NMjhRQWJKWGp6NWNIcFZGR0F4RWJFZXViMk80M19r?oc=5","date":"2025-09-08","type":"trial","source":"FirstWord Pharma","summary":"New gMG contender emerges as Dianthus' claseprubart looks headed for Phase III - FirstWord Pharma","headline":"New gMG contender emerges as Dianthus' claseprubart looks headed for Phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTnZWRWFQZDZjaS05Qi1hUklEWHNoejVxeFN0Z1dScnJEZENkelZfOWNSTWNGbjZOdXFKRzlLY3lteXd5UUpYaGphS1Q3QWROMlU1UzNRc0NzOG1nSkVpS3VqTFNlMzFpM2x2SG9KYnUtd3U4OGxGZmlIclQtNjZWVERYYi1WaHdOU0VTdGxmdVdfZGlqdjRzbmFoX2EyU2NMdURKT2o3ZTFlTlk?oc=5","date":"2025-05-22","type":"pipeline","source":"citybiz","summary":"Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors - citybiz","headline":"Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}